Forsteo®
Forsteo® is a biological therapy with 6 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
0
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study of B-3E07 and Forsteo® in Healthy Adult Female Participants
Bioequivalence Study of SAL001 and FORSTEO in Healthy Chinese Adults
Comparative Study for Incidence of Proximal Junctional Kyphosis Between Parathyroid Hormone and Denosumab Following Adult Spinal Deformity Surgery : A Prospective, Randomized Controlled Trial
Ankle Fractures Treated With Teriparatide
Nasally and sc Administered Teriparatide in Healthy Volunteers
Clinical Trials (6)
A Study of B-3E07 and Forsteo® in Healthy Adult Female Participants
Bioequivalence Study of SAL001 and FORSTEO in Healthy Chinese Adults
Comparative Study for Incidence of Proximal Junctional Kyphosis Between Parathyroid Hormone and Denosumab Following Adult Spinal Deformity Surgery : A Prospective, Randomized Controlled Trial
Ankle Fractures Treated With Teriparatide
Nasally and sc Administered Teriparatide in Healthy Volunteers
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Doses of PTH134 in Post-menopausal Women
All 6 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 6